(Q56899574)

English

Combination of adoptive cell transfer and antibody injection can eradicate established tumors in mice--an in vivo study using anti-OX40mAb, anti-CD25mAb and anti-CTLA4mAb-

article published in 2010

In more languages

Statements

scholarly article

0 references

Combination of adoptive cell transfer and antibody injection can eradicate established tumors in mice--an in vivo study using anti-OX40mAb, anti-CD25mAb and anti-CTLA4mAb- (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

Akira Watanabe

1

0 references

Masaki Hara

2

0 references

Eiichi Chosa

3

0 references

Kunihide Nakamura

4

0 references

Ryo Sekiya

5

0 references

Tetsuya Shimizu

6

0 references

Toshio Onitsuka

7

0 references

language of work or name

0 references

publication date

June 2010

0 references

Immunopharmacology and Immunotoxicology

0 references

32

0 references

2

0 references

238-45

0 references

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Cancer despite immunosurveillance: immunoselection and immunosubversion

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

CTLA-4 can function as a negative regulator of T cell activation

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Spleen plays an important role in maintaining tolerance after removal of the vascularized heart graft

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Immunosuppressive strategies that are mediated by tumor cells

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Cancer immunoediting from immune surveillance to immune escape

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Tumor-infiltrating T lymphocytes: friends or foes?

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Breaking tolerance in cancer immunotherapy: time to ACT.

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Activation requirements for the induction of CD4+CD25+ T cell suppressor function

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Adoptive immunotherapy for cancer: building on success

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Recombinant immunotoxins for the treatment of haematological malignancies

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.3109%2F08923970903222355

21 January 2018

Identifiers

10.3109/08923970903222355

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56899574&oldid=1873331400"